TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 0 | -21 | -22 | -38 | -56 | -15 | -30 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/23/10 15:13 | 2/22/10 | BCLI | Brainstorm Cell Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Stolick David | NY | O | CFO | S | -36 | 0.3600 | 0 | -100 | -40 | 150 | D | -16 | 367 | 500 | 40 | 75 | 45 | 31 | 11 | 0 | -21 | -19 | -33 | -52 | -5 | |
2/19/10 17:14 | 2/12/10 | BCLI | Brainstorm Cell Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Stolick David | NY | O | CFO | S.dm | -54 | 0.3600 | 0 | -150 | -38 | 250 | D | -23 | 270 | 429 | 23 | 42 | 48 | 28 | 3 | 0 | -21 | -24 | -43 | -59 | -24 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |